title: The use of conformational restriction and molecular modeling techniques in the development of receptor-specific opioid peptide agonists and antagonists.
authors.affiliation: Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal, Quebec, Canada.
authors.forename: P W
authors.initials: PW
authors.lastname: Schiller
authors.forename: T M
authors.initials: TM
authors.lastname: Nguyen
authors.forename: G
authors.initials: G
authors.lastname: Weltrowska
authors.forename: N N
authors.initials: NN
authors.lastname: Chung
authors.forename: C
authors.initials: C
authors.lastname: Lemieux
authors.forename: B J
authors.initials: BJ
authors.lastname: Marsden
authors.forename: B C
authors.initials: BC
authors.lastname: Wilkes
mesh_terms: D000595:Amino Acid Sequence; D000818:Animals; D015195:Drug Design; D004723:Endorphins / Q000037:antagonists & inhibitors* / Q000737:chemistry / Q000494:pharmacology*; D006801:Humans; D008958:Models, Molecular; D008968:Molecular Conformation; D008969:Molecular Sequence Data; D009292:Narcotic Antagonists; D011957:Receptors, Opioid / Q000737:chemistry / Q000187:drug effects*
chemical_list: D004723:Endorphins; D009292:Narcotic Antagonists; D011957:Receptors, Opioid